The rigid endoscope market has seen considerable growth due to a variety of factors.
•In recent times, the rigid endoscope market has experienced significant growth. The market size is forecasted to expand from $4.88 billion in 2024 to $5.26 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%.
Factors contributing to the growth during the historical period include global civil disturbances, increasing urbanization and population density, political instability, potential for public disorder at large-scale events, and modernization initiatives in the military and law enforcement sectors.
The rigid endoscope market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the rigid endoscope market is anticipated to experience robust growth. It is projected to expand to "$7.32 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%.
This expected growth over the forecast period can be accredited to factors such as terrorism and asymmetric threats, unrest due to the pandemic, public events and mass gatherings, national security issues, as well as public consciousness and advocacy. The forecast period will also see significant trends such as non-lethal technologies, integrated communication systems, improved riot control vehicles, crowd surveillance and analysis, less-lethal projectiles and ammunition, training simulators, and virtual reality.
The upsurge in cancer rates and gastrointestinal maladies is set to fuel expansion in the rigid endoscope market in the future. The term 'cancer' pertains to irregular cell proliferation causing organ and tissue malfunction. Conversely, gastrointestinal irregularities pertain to digestive system disorders. For diagnostic and treatment purposes for both cancer and gastrointestinal conditions, rigid endoscopes are used. These devices enable medical professionals to look inside a patient's body, conduct biopsies and perform minimally invasive surgery, leading to early detection and effective disease management. For instance, the American Cancer Society, a US-based non-profit focused on cancer advocacy, reported in January 2023 that cancer incidence increased from 1,898,160 cases in 2021 to 1,958,310 cases in 2023, reflecting a growth rate of 3.16%. Further, in March 2021, the International Agency for Research on Cancer reported that globally, gastrointestinal cancers account for one in four cancer cases and one in three cancer deaths. Consequently, the mounting prevalence of cancer and gastrointestinal disorders is propelling growth in the rigid endoscope market.
The rigid endoscope market covered in this report is segmented –
1) By Types: Laparoscope, Arthroscope, Gynecological Endoscope, ENT endoscopy, Urology endoscopy, Neurology endoscopy, Other Types
2) By Hygiene: Single-use, Reprocessing, Sterilization
3) By Applications: Hospital and Clinic, Ambulatory Surgical Centre (ASC), Other Applications
Subsegments:
1) By Laparoscope: Standard Laparoscope, Flexible Laparoscope, High-Definition Laparoscope
2) By Arthroscope: Standard Arthroscope, Miniature Arthroscope, 4K Arthroscope
3) By Gynecological Endoscope: Hysteroscope, Culdoscope, Laparoscopic Gynecological Endoscope
4) By ENT Endoscopy: Nasal Endoscope, Laryngeal Endoscope, Sinus Endoscope
5) By Urology Endoscopy: Cystoscope, Ureteroscope, Nephroscope
6) By Neurology Endoscopy: Neuroendoscope, Rigid Neuroendoscope, Flexible Neuroendoscope
7) By Other Types: Thoracoscope, Mediastinoscope, Bronchoscope
There has been a growing trend towards product innovations within the rigid endoscope market. Key market participants are focusing on developing innovative offerings to cement their presence within the sector. Take for example the medical device company Integrated Endoscopy, based in the US, who in November 2022, launched the Gen II NUVIS. This single-use rigid endoscope, offers 4K resolution, battery-operated and cordless arthroscopy, designed specifically for arthroscopic surgical procedures. The Gen II NUVIS has a unique optical train design that significantly reduces the volume of optical elements by over 60%, whilst enhancing image quality to 4K. Moreover, the production of the Gen II NUVIS will not only offer superior image quality, but will also be less costly and quicker to manufacture, facilitated by the use of high-volume automation. In another breakthrough, the device also includes a built-in battery-powered LED that replaces the traditional lightbox and hefty light cord.
Major companies operating in the rigid endoscope market include:
• Stryker Corporation
• Karl Storz SE & Co. KG
• Richard Wolf GmbH
• Olympus Corporation
• Medtronic plc
• CONMED Corporation
• Smith & Nephew plc
• B Braun Melsungen AG
• Henke-Sass Wolf GmbH
• Ethicon Inc.
• Fujifilm Holdings Corporation
• Integrated Endoscopy Inc.
• NeoScope Inc.
• PENTAX Medical
• Optomic España SA
• Hoya Corporation
• Aesculap Inc.
• Boston Scientific Corporation
• Cook Medical Inc.
• Pristine Surgical LLC
• Allengers Medical Systems Ltd.
• Bausch Health Companies Inc.
• Cardinal Health Inc.
• EndoChoice Holdings Inc.
North America was the largest region in the rigid endoscope market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global rigid endoscope market during the forecast period. The regions covered in the rigid endoscope market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.